Aptarion is dedicated to leveraging the strengths of biostable L-aptamers (highly specific "chemical antibodies") across the biomedical spectrum. Besides the discovery of new L-aptamers for the functionalization of sensors with its powerful platform technology, Aptarion pursues the development of its proprietary existing L-aptamers as therapeutics in areas of high medical need.
| Website | http://www.aptarion.com |
| Revenue | $3 million |
| Employees | 13 (5 on RocketReach) |
| Founded | 2016 |
| Address | 8 10 Max-dohrn-straße, Berlin, Berlin 10589, DE |
| Phone | +49 30 959982133 |
| Technologies | |
| Industry | Biotechnology Research, Business Services General, Business Services |
| Keywords | Biomedical Research, Biosensors, Biotechnology, Drug Discovery, Diagnostic Tools, Biomedical Engineering, Pharmaceutical Research, Molecular Diagnostics, Precision Medicine, Life Sciences, Biomedical Devices, In Vitro Diagnostics, Lab-On-A-Chip, Point-Of-Care Diagnostics |
| Competitors | Roche, Novartis, Merck & Co., Inc., Pfizer, Bristol Myers Squibb, Genentech, Amgen, Regeneron, Gilead Sciences, Lilly India +39 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies |
Looking for a particular Aptarion biotech AG employee's phone or email?
The Aptarion biotech AG annual revenue was $3 million in 2026.
Sven Klussmann is the Founder and Chief Executive Officer (CEO) of Aptarion biotech AG.
5 people are employed at Aptarion biotech AG.
Aptarion biotech AG is based in Berlin, Berlin.
The NAICS codes for Aptarion biotech AG are [541, 54, 541713, 5417, 54171].
The SIC codes for Aptarion biotech AG are [87, 873].